Company intelligence / Profile preview

Saegis Pharmaceuticals

Menlo Park* or Mountain View*?, CA, USAventureradar.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Saegis Pharmaceuticals developed orally available small molecule drugs aimed at improving memory and cognition deficits. Two compounds demonstrated efficacy and safety in human clinical studies. The company built its pipeline through discovery using comparative modeling technology of age-related cognitive decline plus strategic in-license/repositioning of clinical-stage compounds. It completed a Phase IIa clinical study for SGS518 targeting neurological conditions impacting cognition[4].

Therapeutic areas: PsychiatryNeurology
Modalities: Orally available small molecule compounds
Industry: Biotech

Drug pipeline

1 asset

SGS518

Phase 2

Indications: Cognitive Impairment Associated with Schizophrenia

Partnerships

No major partnerships explicitly listed beyond investment support from venture firms including Versant Ventures, Technology Partners, Sofinnova Ventures US & Paris branches, Polaris Venture Partners, NeuroVentures; also supported by Stanley Medical Research Institute and Novartis Pharma AG before acquisition[4].

Beyond the preview

Go deeper on Saegis Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saegis Pharmaceuticals.

Explore the full profile